Published October 20, 2025 | Version 20251020
Software Open

jingxinfu/primary_hr_brca_io_treated_genomic_analysis: Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone-receptor positive breast cancer: A randomized pilot trial

Authors/Creators

  • 1. Dana-Farber Cancer Institute

Description

Scripts for analyzing WES and bulk RNA-Seq data associated with the publication "Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor–positive breast cancer: A randomized pilot trial."

Files

jingxinfu/primary_hr_brca_io_treated_genomic_analysis-20251020.zip

Files (22.0 MB)

Additional details

Related works

Is supplement to
Software: https://github.com/jingxinfu/primary_hr_brca_io_treated_genomic_analysis/tree/20251020 (URL)

Software

Repository URL
https://github.com/jingxinfu/primary_hr_brca_io_treated_genomic_analysis